XML 45 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Equity (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Common Stock
Series B Cumulative Redeemable Preferred Stock
Additional Paid in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Non- controlling Interests — Common units in the Operating Partnership
Non-controlling Interest — Members in Consolidated Entities
Non- controlling Interests — Series A Cumulative Redeemable Preferred Units
Beginning balance (in usd) at Dec. 31, 2012 $ 897,222     $ 726,605          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Amortization of stock-based compensation       5,159          
Cash flow hedge adjustment (731)                
Ending balance (in usd) at Sep. 30, 2013                  
Beginning balance (in usd) at Dec. 31, 2012 897,222 475 145,000 726,605 (30,580) (1,287) 55,549 1,460 12,475
Beginning balance (in shares) at Dec. 31, 2012   47,496,732              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Contributions 45,704             45,704  
Distributions (1,160)             (1,160) (2,000)
Proceeds from sale of common stock, net of underwriters' discount (in shares)   9,812,644              
Proceeds from sale of common stock, net of underwriters’ discount (in usd) 202,542 98   202,444          
Common stock issuance transaction costs (577)     (577)          
Issuance of unrestricted stock   5,756              
Issuance of restricted stock   44,219              
Forfeiture of restricted stock   (3,415)              
Shares repurchased (in shares)   (125,737)              
Shares repurchased (in usd) (2,756) (1)   (2,755)          
Declared dividend (41,751)   (12,144) (28,415)     (1,192)   (749)
Amortization of stock-based compensation 6,682     6,682          
Net income (loss) (3,343)   12,144   (14,533)   (633) (321) 749
Cash flow hedge adjustment 303         290 13    
Ending balance (in usd) at Dec. 31, 2013 1,102,866 572 145,000 903,984 (45,113) (997) 53,737 45,683 10,475
Ending balance (in shares) at Dec. 31, 2013 57,230,199 57,230,199              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Distributions (2,385)             (2,385)  
Proceeds from sale of common stock, net of underwriters' discount (in shares)   9,563,500              
Proceeds from sale of common stock, net of underwriters’ discount (in usd) 197,468 96   197,372          
Common stock issuance transaction costs (674)     (674)          
Redemption of Series A Cumulative Redeemable Preferred Units                 (298)
Issuance of unrestricted stock   5,098              
Shares repurchased (in shares)   (2,805)              
Shares repurchased (in usd) 0     0          
Declared dividend (35,142)   (9,108) (25,140)     (894)   (482)
Amortization of stock-based compensation 5,320     5,320          
Net income (loss) 22,155   9,108   12,451   441 155 482
Cash flow hedge adjustment (780)         (752) (28)    
Ending balance (in usd) at Sep. 30, 2014 $ 1,288,828 $ 668 $ 145,000 $ 1,080,862 $ (32,662) $ (1,749) $ 53,256 $ 43,453 $ 10,177
Ending balance (in shares) at Sep. 30, 2014 66,795,992 66,795,992